Published
In this brief 5-minute video, Dr. Todd M. Bauer reviews the history of next-generation sequencing for targeted therapies in advanced non-small cell lung cancer and discusses the differences between DNA and RNA-based sequencing technologies for these patients.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
18:11
Part 1: Targeted Therapy for NSCLC: Toxicity Profile of ADCs
-
11:21
Collective Illusions: Conformity, Complicity,… by Todd Rose · Audiobook preview
-
15:01
Utilizing DNA and RNA in Advanced NSCLC
-
17:02
A Turning Point in HER2-Mutated NSCLC: What Clinicians Need to Know Now
-
05:35
The latest NSCLC data presented at ELCC 2025
-
04:27
Living with HER2-mutated NSCLC
-
08:01
BOOK REVIEW ~ The Psychology Of Money by Morgan Housel | Review by Hariharan Iyer
-
04:05
Disparities in biomarker-targeted therapy for resected NSCLC
-
06:24
Prostate Cancer | Todd’s Experience
-
18:13
180. Back to Basics - Metastatic NSCLC feat. KRAS and MET mutations
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
